InvestorNewsBreaks

Tuesday Jun 17, 2025 - 10:21 am

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Launches Biofuel Crop Optimization Project with Brookhaven Lab

Datavault AI (NASDAQ: DVLT) is spearheading the development of an AI-driven multi-modal machine learning system to accelerate biofuel crop optimization, targeting increased fatty acid metabolism in canola (Brassica napus). In collaboration with the U.S. Department of Energy’s Brookhaven National Laboratory, the project applies high-performance computing and digital twin technology to model metabolic pathways and reduce the development time for commercially viable biofuel crops. With U.S.…

Tuesday Jun 17, 2025 - 9:20 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Begins First MS Patient Scan in MGH PET Imaging Study

Quantum BioPharma (NASDAQ: QNTM) has announced that the first multiple sclerosis patient has been scanned in a collaborative study with Massachusetts General Hospital to validate a novel PET imaging technique for tracking myelin integrity. The study uses the tracer [18F]3F4AP, developed by MGH’s Dr. Pedro Brugarolas, which has shown high sensitivity to demyelinated lesions. Scanning took place on a new GE Signa PET-MR scanner, enabling simultaneous…

Tuesday Jun 17, 2025 - 9:15 am

InvestorNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Launches $3.3 Million Private Placement to Advance Montauban Project

ESGold (CSE: ESAU) (OTCQB: ESAUF) announced a non-brokered private placement of units priced at $0.73 each, targeting gross proceeds of up to $3.285 million. Each unit comprises one common share and one share purchase warrant, exercisable at $0.91 for 18 months. The initial closing is scheduled for June 20, 2025, with additional tranches possible. Proceeds will support mill circuit construction, final mobilization at the Montauban…

Tuesday Jun 17, 2025 - 9:10 am

InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast

Intelligent Bio Solutions (NASDAQ: INBS) CEO Harry Simeonidis joined the latest episode of The BioMedWire Podcast to discuss the company’s rapid, non-invasive drug screening platform and global expansion strategy. Simeonidis detailed how the company’s fingerprint-based technology detects drug use through sweat, enabling faster and more affordable workplace screening. With current deployments in about 20 countries and an FDA application under review, Intelligent Bio Solutions is…

Tuesday Jun 17, 2025 - 9:00 am

InvestorNewsBreaks – Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) Secures $4.5 Million and Extends National Marketing Campaign

Foremost Clean Energy (NASDAQ: FMST) (CSE: FAT) announced a strengthened financial position with over $4.5 million raised through recent warrant and option exercises by insiders and investors. The added capital supports ongoing exploration and drilling initiatives amid rising uranium prices and a forecasted structural supply deficit. Concurrently, the company is extending its strategic investor awareness campaign with LFG Equities Corp., aimed at highlighting Foremost’s unique…

Tuesday Jun 17, 2025 - 9:00 am

InvestorNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Partners with Qingling Motors to Develop Intelligent Commercial Vehicle Solutions

FingerMotion (NASDAQ: FNGR) announced that its subsidiary, JiuGe Technology, is collaborating with Qingling Motors to co-develop intelligent vehicle solutions aimed at improving efficiency and sustainability in commercial mobility. The partnership targets high-demand sectors like logistics and emergency response, with Qingling leading vehicle design and compliance while JiuGe contributes software integration and smart system development. A joint technical taskforce has been formed to accelerate innovation, share…

Tuesday Jun 17, 2025 - 9:00 am

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) and AccurKardia Join Forces to Advance Remote Cardiac Monitoring

HeartBeam to integrate AccurECG(TM), AccurKardia’s FDA-cleared ECG analysis software Collaboration enhances HeartBeam’s commercial offering with automated arrhythmia insights Combined platform aims to improve cardiac care access and speed time to diagnosis HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with AccurKardia, a leader in automated ECG diagnostics, to integrate its FDA-cleared AccurECG(TM) software into HeartBeam’s cable-free, credit card-sized 3D ECG device. The partnership unites two innovators…

Monday Jun 16, 2025 - 2:00 pm

InvestorNewsBreaks – ROTH’s 15th Annual London Conference to Showcase Market Trends, Compelling Investment Opportunities

Roth Capital Partners (“ROTH”), www.roth.com, today announced the agenda and details for its 15th Annual London Conference, which is slated to take place at the Four Seasons Hotel at Park Lane in London on June 24-26, 2025. The event is designed to foster meaningful dialogue between institutional investors and C-suite leaders and senior executives from approximately 80 companies with a strong focus on the sustainability…

Monday Jun 16, 2025 - 10:10 am

InvestorNewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Reports Complete Response in Advanced NSCLC Patient in HARMONIC(TM) Trial

Lantern Pharma (NASDAQ: LTRN) announced a remarkable clinical outcome in its Phase 2 HARMONIC(TM) trial, with a 70-year-old never-smoker with advanced non-small cell lung cancer (NSCLC) achieving a durable complete response following treatment with LP-300 in combination with standard chemotherapy. The patient, who had previously failed three lines of therapy including Keytruda(R), radiation, and Tagrisso(R), initially saw a 57% tumor reduction and later achieved full resolution…

Monday Jun 16, 2025 - 9:20 am

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its subsidiary HOPE Therapeutics announced a strategic investor relations partnership with astr partners, a boutique firm specializing in life sciences. The collaboration comes as NRx advances toward two NDA filings, an ANDA submission, and expands its interventional psychiatry clinic acquisitions. Led by veterans of The Trout Group, astr will support NRx and HOPE with investor targeting,…

Monday Jun 16, 2025 - 9:10 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Presents Positive Phase 3 Data on Fibromyalgia Drug at EULAR 2025

Tonix Pharmaceuticals (NASDAQ: TNXP) presented new data at the 2025 Annual European Congress of Rheumatology (EULAR) in Barcelona supporting TNX-102 SL, its sublingual cyclobenzaprine formulation for fibromyalgia. The poster highlighted results from the RESILIENT Phase 3 trial showing statistically significant, sustained pain reduction over 14 weeks, along with improved sleep and favorable tolerability. Designed to bypass first-pass liver metabolism, TNX-102 SL achieved higher nighttime cyclobenzaprine…

Monday Jun 16, 2025 - 9:05 am

InvestorNewsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 2.4 MW Community Solar Project in Nova Scotia

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) announced progress on its 2.4 MW DC Sydney project in Nova Scotia, reinforcing its expansion in the Canadian community solar market. Valued at $4.57 million and developed in partnership with AI Renewable Flow-through Fund and Trimac Engineering, the project is expected to produce 2,730 MWh of clean energy annually—enough to power 221 homes and offset 1,900 tons…

Monday Jun 16, 2025 - 9:00 am

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG

HeartBeam’s credit card-sized device demonstrated 93.4% diagnostic agreement with standard ECGs VALID-ECG study results presented at Heart Rhythm Society conference Company eyes U.S. commercialization pending FDA clearance HeartBeam (NASDAQ: BEAT) announced its synthesized 12-lead ECG met clinical endpoints in the VALID-ECG pivotal study, achieving 93.4% diagnostic agreement with standard ECGs for arrhythmia assessment. The findings, presented by Dr. Thomas Deering of Piedmont Heart Institute at…

Friday Jun 13, 2025 - 3:41 pm

InvestorNewsBreaks – SolarBank Corp.’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Forest Hill Rd Project Adds to Growing Development Pipeline

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) was featured in a recent article that discussed its momentum with the development of its Forest Hill Rd solar project in upstate New York. “The 4.584 megawatt DC installation will operate as a community solar facility, contributing renewable energy to the local grid and offering cost savings to approximately 540 homes,”…

Friday Jun 13, 2025 - 2:49 pm

InvestorNewsBreaks – Driving the Future of Powersports: Massimo Group’s (NASDAQ: MAMO) Bold Strategy for Market Growth

As the powersports and recreational watercraft industries experience a notable upswing, Massimo Group (NASDAQ: MAMO) is taking a proactive approach through domestic manufacturing, strategic partnerships, and product diversification—initiatives that position the company to capitalize on emerging opportunities. Fueled by growing consumer enthusiasm for outdoor recreation and the multi-purpose appeal of vehicles like those in Massimo’s lineup, the global powersports market—valued at $37.96 billion in 2023—is…

Friday Jun 13, 2025 - 2:36 pm

InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reported Q1 2025 Results, Advanced Toward Commercialization Following VALID-ECG Study Success

HeartBeam (NASDAQ: BEAT) reported financial results and operational highlights for the first quarter of 2025, marking significant progress toward commercialization of its 12-lead ECG synthesis software. The company successfully met clinical endpoints in its VALID-ECG pivotal study, demonstrating a 93.4% diagnostic agreement with standard ECGs, and engaged in productive discussions with the FDA on its 510(k) submission. During the quarter, HeartBeam entered a strategic collaboration…

Friday Jun 13, 2025 - 2:10 pm

InvestorNewsBreaks – Why Beeline Holdings Inc. (NASDAQ: BLNE) Is ‘One to Watch’

Beeline Holdings (NASDAQ: BLNE) is a technology-forward mortgage and title platform leveraging AI, automation, and intuitive user experiences to simplify home financing. “Through wholly owned subsidiary Beeline Loans Inc., the company delivers fast and flexible loan solutions for both primary homebuyers and real estate investors. Beeline has built an end-to-end digital lending ecosystem designed to eliminate friction, reduce costs, and dramatically shorten closing timelines,” reads…

Friday Jun 13, 2025 - 10:55 am

InvestorNewsBreaks – RedCloud Holdings plc (NASDAQ: RCT) to Participate in ROTH 15th Annual London Conference

RedCloud Holdings (NASDAQ: RCT) announced that CEO and Co-Founder Justin Floyd will attend the ROTH 15th Annual London Conference, taking place at the Four Seasons Hotel London at Park Lane. The event provides a platform for RedCloud to engage with investors and industry stakeholders in an international setting. To view the full press release, visit https://ibn.fm/VPEqF About RedCloud RedCloud has developed and operates the RedCloud trading…

Friday Jun 13, 2025 - 9:15 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Plans Special Dividend Linked to Litigation Proceeds

Quantum BioPharma (NASDAQ: QNTM) announced plans to issue a special dividend in the form of Contingent Value Rights (“CVRs”) to holders of its Class B Subordinate Voting Shares on a 1:1 basis. The CVRs will entitle shareholders to a pro rata share of between 10% and 50% of any net proceeds recovered from the company’s pending $700 million+ litigation against several banks over alleged stock manipulation.…

Friday Jun 13, 2025 - 9:10 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Highlights Progress on Phase 3 Psychedelic Therapeutics Program

Cybin (NYSE American: CYBN) (NEO: CYBN) issued a corporate update emphasizing continued momentum in its clinical pipeline, including the advancement of its lead candidate CYB003 into Phase 3 development. CEO Doug Drysdale underscored the growing regulatory clarity around psychedelic therapeutics and expressed optimism that Cybin’s IP portfolio and clinical strategy position the company to help transform mental health treatment. Drysdale also noted favorable shifts in…

Friday Jun 13, 2025 - 9:00 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Jim Hunter to Board of Directors

Tonix Pharmaceuticals (NASDAQ: TNXP) a fully-integrated biotechnology company with marketed products and late-stage development candidates, announced the appointment of James “Jim” Hunter to its Board of Directors, effective June 12. Hunter previously served as Executive Vice President, Commercial, where he built the Company’s commercial subsidiary, Tonix Medicines, and led its entry into the migraine market. CEO Dr. Seth Lederman cited Hunter’s operational insight and commercial…

Friday Jun 13, 2025 - 9:00 am

InvestorNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Elects Board, Names Bruce Hansen as New Chair

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium and rare earth elements, announced the results of its annual and special meeting of shareholders held virtually on June 11. All eleven director nominees were elected with strong shareholder support, and Bruce D. Hansen was appointed Chair of the Board, succeeding J. Birks Bovaird, who had held the role since 2006 and…

Thursday Jun 12, 2025 - 12:54 pm

InvestorNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Advances Clinical Programs, Eyes Critical Trial Results in 2025–2026

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company dedicated to developing and commercializing treatments for rare diseases. The company recently announced its financial results for the first quarter of 2025 as well as accomplishments representative of Soligenix’s continued commitment to advance its pipeline of therapeutic candidates, focusing on areas with significant unmet medical needs. “Our strategic focus remains on advancing our clinical programs, and we…

Thursday Jun 12, 2025 - 11:24 am

InvestorNewsBreaks – FAVO Capital Inc. (FAVO) Targets SMB Lending Gap with Digital Platform, Custom Solutions

FAVO Capital (OTC: FAVO) is developing a digital lending platform to address the persistent financing gap faced by underserved small and medium-sized businesses (“SMBs”). Traditional banks often deny credit to these businesses due to outdated underwriting models, creating a market ripe for disruption. FAVO is responding with fast, flexible, and accessible capital solutions for SMBs that are often overlooked. With more than 5.5 million new…

Thursday Jun 12, 2025 - 10:04 am

InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights Growth and SEPA Funding Ahead of BIO 2025 CEO Participation

Scinai Immunotherapeutics (NASDAQ: SCNI) announced that CEO Amir Reichman will participate in the BIO International Convention 2025, taking place June 16–19 in Boston. The company will present recent strategic, operational, and financial milestones, including its rapid CDMO business growth and progress on its nanobody pipeline. Scinai recently secured $1.38 million in funding via its Standby Equity Purchase Agreement with Yorkville Advisors, boosting capital without warrants…

Thursday Jun 12, 2025 - 9:23 am

InvestorNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Files Updated Resource Estimate for Condor Gold Project in Ecuador

Silvercorp Metals (TSX: SVM) (NYSE American: SVM) has filed an updated mineral resource estimate for its Condor gold project in Ecuador. The filing follows its May 12, 2025, announcement and includes the "Independent Technical Report for the Condor Project, Ecuador," prepared by SRK Consulting (Canada) Inc., with an effective date of Feb. 28, 2025. To view the full press release, visit https://ibn.fm/KRqia About Silvercorp Silvercorp…

Thursday Jun 12, 2025 - 9:11 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Speak at H.C. Wainwright Neuro Perspectives Conference

Cybin (NYSE American: CYBN) (NEO: CYBN) announced that Chief Executive Officer Doug Drysdale will participate in a virtual fireside chat at the H.C. Wainwright 6th Annual Neuro Perspectives Conference, scheduled for June 16–17, 2025. The company is advancing next-generation neuropsychiatric treatments aimed at transforming mental healthcare. To view the full press release, visit https://ibn.fm/BjhYH About Cybin Inc. Cybin is a clinical-stage biopharmaceutical company on a…

Thursday Jun 12, 2025 - 9:10 am

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics to Present at H.C. Wainwright Neuro Perspectives Conference

NRx Pharmaceuticals (NASDAQ: NRXP) and its wholly owned subsidiary HOPE Therapeutics, Inc. announced participation in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference, set for June 16–17, 2025. Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx and Co-CEO of HOPE, will deliver a corporate presentation highlighting recent developments, available on demand to registered attendees starting at 7 a.m. ET on June 16. The…

Thursday Jun 12, 2025 - 9:00 am

InvestorNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Launches Exploration at Storm Copper Project in Nunavut

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) announced the start of exploration activities at its Storm Copper Project on Somerset Island, Nunavut. Operated by American West Metals under a 20/80 joint venture, with Aston Bay retaining a free carried interest until a mining decision follows a bankable feasibility study, the program will include reverse circulation and diamond drilling targeting both resource expansion and deeper discoveries. A…

Wednesday Jun 11, 2025 - 3:09 pm

InvestorNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) Trades Below S&P 500 Amid “Value Trap” Debate

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) is currently valued at ~19× forward earnings—below the S&P 500 average of 22.5×—making it the cheapest of the “Magnificent Seven” and sparking discussion about whether its low price represents value or a potential trap. While its search dominance is under siege from AI challengers like ChatGPT and regulatory pressure could force asset divestitures, Alphabet also boasts strong assets—YouTube, Google Cloud, and…

Wednesday Jun 11, 2025 - 2:56 pm

InvestorNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Expands ‘Below Expectations’ Ratings in Midyear Reviews

Meta Platforms (NASDAQ: META) is reportedly preparing to invest approximately $14.8 billion for a 49% stake in Scale AI, a leading provider of data-labeling services critical to AI model training. As part of the deal, Scale AI’s CEO, Alexandr Wang, will join Meta to spearhead a new “superintelligence” lab alongside a 50person research team personally led by Mark Zuckerberg. The move comes in the wake of underperforming…

Wednesday Jun 11, 2025 - 2:51 pm

InvestorNewsBreaks – Why Vivakor Inc. (NASDAQ: VIVK) Is ‘One to Watch’

Vivakor (NASDAQ: VIVK), a vertically integrated energy infrastructure and environmental services company, is focused on the transportation, storage, reuse, and remediation of oilfield fluids and waste. “The company operates a large-scale oilfield trucking fleet, serving key U.S. energy regions, enabling end-to-end solutions for the handling of crude oil and produced water. Through long-term contracts and strategic asset positioning, Vivakor delivers critical services to upstream energy…

Wednesday Jun 11, 2025 - 1:45 pm

InvestorNewsBreaks – Snap Inc. (NYSE: SNAP) Unveils Next‑Gen “Specs” AR Glasses and Snap OS Enhancements

Snap (NYSE: SNAP) announced at the Augmented World Expo 2025 that its next-generation AR glasses, dubbed Specs, will be launched to consumers in 2026. These ultra‑lightweight, standalone wearable computers boast see-through lenses overlaying digital content on the real world and come powered by on-device AI. Snap OS is also receiving major upgrades: deep integrations with OpenAI and Google’s Gemini, a depth-module API for 3D spatial…

Wednesday Jun 11, 2025 - 1:35 pm

InvestorNewsBreaks – NVIDIA Corp. (NASDAQ: NVDA) Sparks Rally in Quantum Stocks After Declaring “Inflection Point”

NVIDIA (NASDAQ: NVDA) ignited a surge in quantum computing stocks after CEO Jensen Huang declared the industry had reached an “inflection point,” reversing prior skepticism about near-term applications. Speaking at the VivaTech conference, Huang said NVIDIA’s Cuda-Q platform is now enabling practical quantum-classical hybrid solutions in fields like chemistry and finance. The announcement boosted investor confidence in the space, sending shares of Quantum Computing Inc.…

Wednesday Jun 11, 2025 - 1:25 pm

InvestorNewsBreaks – Tesla Inc. (NASDAQ: TSLA) Delays Robotaxi Launch, Stock Rallies After Musk Calms Trump Feud

Tesla (NASDAQ: TSLA) announced a tentative June 22 debut of its long-awaited robotaxi service in Austin, Texas, following Elon Musk’s temporary retreat from a public spat with former President Trump. Musk indicated the launch date could shift as the company remains “super paranoid about safety.” Investor optimism returned, with analysts pointing to the rollout as a pivotal step toward scaling its autonomous ride-hailing ambitions—even as questions…

Wednesday Jun 11, 2025 - 1:15 pm

InvestorNewsBreaks – Broadcom Inc. (NASDAQ: AVGO) Rebounds as AI Growth Outpaces Tepid Guidance

Broadcom (NASDAQ: AVGO) shares climbed after the company posted strong fiscal Q2 results, with a 20% year-over-year revenue increase to $15 billion, fueled by a 46% surge in AI-related chip sales totaling $4.4 billion. While forward guidance was more reserved, the standout AI performance overshadowed broader concerns, prompting analyst upgrades and renewed investor confidence in Broadcom’s long-term positioning in the data infrastructure and AI markets.…

Wednesday Jun 11, 2025 - 11:01 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Receives USPTO Notice of Allowance for PTSD Treatment Patent

Silo Pharma (NASDAQ: SILO) announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for its licensed patent application related to biomarkers for evaluating prophylactic treatments for stress-induced affective disorders. The patent, set to be issued as U.S. Patent No. 12,329,726 on June 17, 2025, bolsters Silo’s intellectual property around its lead candidate SPC-15, an intranasal PTSD treatment licensed from Columbia…

Wednesday Jun 11, 2025 - 10:05 am

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Breakthrough with Telomir-1 in Wilson’s Disease Model

Telomir Pharmaceuticals (NASDAQ: TELO) announced new preclinical data showing its lead candidate, Telomir-1, significantly reversed neurological, liver, and kidney symptoms in a genetic animal model of Wilson's disease, a rare disorder caused by copper accumulation. In zebrafish mimicking human pathology, Telomir-1 delivered a 4- to 5-fold reduction in tremors, normalized movement behaviors, cut liver copper levels by 50%, improved organ histopathology, and restored key liver…

Wednesday Jun 11, 2025 - 9:36 am

InvestorNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Forms Strategic Alliance with Toronto Blizzard to Develop Global Soccer Talent Pipeline

Brera Holdings (NASDAQ: BREA) announced a strategic advisory agreement with Toronto Blizzard Corp., Canada's top soccer scholarship academy, to create a pathway for youth players into professional soccer by linking Blizzard’s development programs with Brera’s multi-club global network. Targeting the $69 billion youth sports and $37 billion sports tourism markets, the initiative aims to develop players ages 3 to 18 through shared coaching methodologies and…

Wednesday Jun 11, 2025 - 9:23 am

InvestorNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) CEO Talks Near-Term Production and Clean Mining Focus on Exploring Mining Podcast

ESGold (CSE: ESAU) (OTCQB: ESAUF) CEO and Director Paul Mastantuono joined the Exploring Mining Podcast to discuss the company’s fully permitted, near-production Montauban Project in Quebec. In the interview, Mastantuono highlighted ESGold’s strategic shift toward surface-accessible resources like tailings and low-cost ore bodies, positioning the company for accelerated production without the typical drilling-heavy approach of junior miners. He also covered recent leadership additions, share structure…

InvestorNewsBreaks

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions